AlzeCure Selects Drug Candidate and Enters Next Phase of Development with TrkA-NAM ACD137 against Severe Pain

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / January 29, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR, a…

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration for Heart Murmur Detection at Arab Health 2024

2 years ago

Offering Free Heart Checks to Mark 75 Years of Excellence in Healthcare InnovationJUNGINGEN, Germany--(BUSINESS WIRE)--Rudolf Riester GmbH, a global leader…

Tri Sprout Kratom Redefines Wellness in Las Vegas

2 years ago

LAS VEGAS, NV / ACCESSWIRE / January 27, 2024 / Tri Sprout Kratom, a Las Vegas deeply rooted in the…

Sirona Biochem Initiates Private Placement

2 years ago

VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF) (the "Company") is…

Vision Sensing Acquisition Corp. Responds to NASDAQ Letter and Hopeful of Expedient Resolution

2 years ago

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company” or “VSAC”),…

Daré Bioscience Announces Executive Team and Board of Directors Changes

2 years ago

SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today…

BrightSpring Celebrates First Day of Trading on Nasdaq

2 years ago

Will Make $100 Million Equity Grant to 20,000 EmployeesLOUISVILLE, Ky., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc.…

Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering

2 years ago

Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX” THE WOODLANDS, TX., Jan. 26,…

NADP and ADA Achieve Loss Ratio Compromise at NCOIL

2 years ago

Model legislation offers middle ground solution on loss ratiosDALLAS, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The National Association of Dental…

AB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines Agency

2 years ago

PRESS RELEASE AB SCIENCE ANNOUNCES AN UPDATE IN THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AT THE…